Spots Global Cancer Trial Database for Rasburicase in Tumor Lysis Syndrome
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Rasburicase in Tumor Lysis Syndrome
Official Title: Program of Rasburicase in the Treatment of Hyperuricemia in Children and Adolescent Patients With or at Risk of Tumor Lysis Syndrome.
Study ID: NCT00302653
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine whether rasburicase is effective and safety in correcting hyperuricemia.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sanofi-aventis administrative office, São Paulo, , Brazil
Contact Details
Name: Jaderson Lima
Affiliation: Sanofi-aventis administrative office Brazil
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
